Home
Conditions
Skin Diseases, Vesiculobullous

Clinical trial condition

Skin Diseases, Vesiculobullous

Explore clinical trials studying Skin Diseases, Vesiculobullous. Study availability and eligibility vary by location and protocol.

235 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Skin Diseases, Vesiculobullous trial results

Completed

A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid

NCT05267600

Conditions: Autoimmune Diseases, Bullous Pemphigoid, Immune System Diseases, +4 more
Locations: Investigator site 74 - US0010178 Phoenix, Arizona, United States

Investigator site 6 - US0010138 Fountain Valley, California, United States

Investigator site 121 - US0010092 Redwood City, California, United States

Investigator site 72 - US0010186 Santa Monica, California, United States

View all 129 locations

View Trial Details

Completed

Prevalence of Sleep Disturbances in Bullous Pemphigoid Patients.

NCT07188402

Conditions: Autoimmune Diseases, Bullous Pemphigoid (BP), Immune System Diseases, +4 more
Locations: University Rouen Hospital Rouen, France

View Trial Details

Completed

Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN

NCT06474078

Conditions: Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +15 more
Locations: Chang Gung Memorial Hospital Taoyuan, Taiwan

View Trial Details

Completed

A Pilot Study to Evaluate a Temporary Skin Substitute (Spincare® Matrix) for Wound Healing in RDEB Patients

NCT05944250

Conditions: Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Discovery Hall Stanford University Redwood City, California, United States

View Trial Details

Completed

Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid

NCT05984381

Conditions: Autoimmune Diseases, Blister, Bullous Pemphigoid, +7 more
Locations: AIIMS Bhubaneswar Bhubaneswar, Odisha, India

View Trial Details

Completed

Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC

NCT04177498

Conditions: Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin

NCT00923104

Conditions: Blister, Breast Cancer, Breast Diseases, +18 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray Solution

NCT05533866

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +6 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Completed

rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects

NCT04035733

Conditions: Autoimmune Diseases, Bullous Pemphigoid (BP), Immune System Diseases, +4 more
Locations: University of Lubeck Lübeck, Germany

UMCG Groningen Groningen, Hanzeplein 1, Netherlands

View Trial Details

Completed

Gynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)

NCT04757727

Conditions: Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: CHU de NICE Nice, France

Hôpital Saint Louis Paris, France

View Trial Details

Skin Diseases, Vesiculobullous

Skin Diseases, Vesiculobullous trial results

Related conditions